Bioaffinity Technologies, Inc. (BIAF) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by bioAffinity Technologies, Inc. on August 20, 2026. The report details a material modification to the rights of security holders regarding a reverse stock split approved by stockholders at the Annual Meeting on April 30, 2026, and subsequently implemented by the Board of Directors.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and capital structure adjustments rather than financial performance results.
Material Changes
- Reverse Stock Split: The Company implemented a 1-for-15 reverse split of its outstanding Common Stock.
- Effective Date: The split became effective at 4:01 p.m. Eastern Time on August 21, 2026.
- Trading Resumption: Common stock began trading on a split-adjusted basis on August 24, 2026, on the Nasdaq Capital Market under the symbol "BIAF".
- Security Identification: A new CUSIP number (09076W406) has been assigned to the security.
- Adjustments: Proportionate adjustments were made to the exercise price and share counts for outstanding stock options, restricted stock units, and warrants.
- Fractional Shares: Stockholders entitled to fractional shares received cash in lieu thereof.
Outlook, Risks, and Management Commentary
Purpose: The primary objective of the reverse stock split is to bring the Company into compliance with Nasdaq's minimum bid price requirement.
Ownership Impact: The split affects all stockholders uniformly and does not alter any stockholder's percentage ownership interest in the Company, excluding the cash settlement for fractional shares.
Regulatory Disclosure: The Company issued a press release on August 20, 2026, regarding this event, which is furnished under Item 7.01 (Regulation FD Disclosure) and is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the new CUSIP number (09076W406) for trading and record-keeping purposes.
- Confirm the adjusted number of shares held post-split (1 share for every 15 pre-split shares).
- Check for cash payments received in lieu of fractional shares.
- Review the adjusted exercise prices and share quantities for any held options, RSUs, or warrants.
- Monitor the stock price on August 24, 2026, to ensure compliance with Nasdaq listing requirements is maintained.